Strategies of Combination Drug Delivery for Immune Checkpoint Blockades

Huitong Ruan1,2,3,4, Linlin Bu2,3, Quanyin Hu2,3

  • 1Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Fudan University, Shanghai, 201203, China.

Insights

Immune checkpoint blockades (ICB) show promise but have limitations. Combining ICB with other cancer therapies targeting the immune cycle may improve response rates and manage side effects.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Therapy

Background:

  • Immune checkpoint blockades (ICB) have advanced cancer treatment by blocking regulatory receptors to enhance antitumor T-cell responses.
  • Limitations of ICB include low objective response rates (ORR) and immune-related side effects.
  • Combination treatment strategies are crucial for overcoming ICB limitations.

Purpose of the Study:

  • To review recent advancements in combining ICB with therapies targeting various stages of the cancer immune cycle.
  • To discuss the challenges and opportunities associated with ICB combination approaches.

Main Methods:

  • Literature review of recent studies on ICB combination therapies.
  • Analysis of therapies targeting different phases of the cancer immune cycle: antigen release, presentation, T-cell activation, recognition, and tumor killing.

Main Results:

  • ICB combination strategies are being explored across all stages of the cancer immune cycle.
  • These combinations aim to enhance antitumor immunity and mitigate adverse effects.
  • The review highlights progress in integrating ICB with diverse therapeutic modalities.

Conclusions:

  • Combining ICB with other cancer therapies holds significant potential for improving treatment efficacy.
  • Addressing challenges in combination strategies is key to realizing their full therapeutic benefit.
  • Further research into ICB combinations offers opportunities to advance cancer immunotherapy.

Related Concept Videos

Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.0K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.8K
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
849
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.9K